In compliance with regulation 30 read with schedule III, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vivimed Labs has informed that a conference call with analysts/investors is scheduled to be held on Friday, June 1, 2018 at 5:30 PM to discuss operational and financial performance of Q4 & FY18.
The above information is a part of company’s filings submitted to BSE.